Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment for Advanced Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT02404363
What this trial is testing

Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy

Who this might be right for
Locally Advanced Pancreatic CancerAdenocarcinoma, PancreasMetastatic Pancreatic Cancer
Assistance Publique - Hôpitaux de Paris 39
Testing effectiveness (Phase 2)Study completedNCT00085371
What this trial is testing

Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
National Cancer Institute (NCI) 116
Early research (Phase 1)Study completedNCT02959164
What this trial is testing

Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaSarcoma
Mohammed Milhem 36
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT02382263
What this trial is testing

Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
PH Research, S.L. 224
Testing effectiveness (Phase 2)Study completedNCT00383760
What this trial is testing

Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients

Who this might be right for
Adenocarcinoma of the PancreasPancreatic CancerRecurrent Pancreatic Cancer+3 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00062283
What this trial is testing

Alanosine in Treating Patients With Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaPancreatic Cancer+1 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT07645651
What this trial is testing

Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced Pancreatic Ductal Adenocarcinoma
University of Washington 15
Early research (Phase 1)UnknownNCT00010270
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer

Who this might be right for
Colorectal CancerEsophageal CancerGastric Cancer+1 more
University Hospital Freiburg 50
Testing effectiveness (Phase 2)Looking for participantsNCT04146298
What this trial is testing

Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic NeoplasmsPancreatic Ductal Adenocarcinoma+1 more
Changhai Hospital 30
Testing effectiveness (Phase 2)UnknownNCT02737228
What this trial is testing

Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
CrystalGenomics, Inc. 24
Early research (Phase 1)Study completedNCT05415475
What this trial is testing

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerEsophageal CancerStomach Cancer+3 more
Chongqing Precision Biotech Co., Ltd 30
Not applicableStudy completedNCT04631445
What this trial is testing

Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Translational Drug Development 32
Testing effectiveness (Phase 2)Study completedNCT04469556
What this trial is testing

Pancreatic Adenocarcinoma Signature Stratification for Treatment

Who this might be right for
Pancreatic Cancer MetastaticPancreatic Ductal AdenocarcinomaAdvanced Pancreatic Cancer
University Health Network, Toronto 150
Early research (Phase 1)Looking for participantsNCT06043466
What this trial is testing

A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerEsophagus CancerGastric Cancer+4 more
Chongqing Precision Biotech Co., Ltd 30
Early research (Phase 1)Looking for participantsNCT07189195
What this trial is testing

TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmMetastatic Pancreatic Adenocarcinoma+5 more
University of California, Davis 52
Not applicableStudy completedNCT04699539
What this trial is testing

Different Patterns of Target Delineation in SBRT for Locally Advanced Pancreatic Cancer

Who this might be right for
Treatment
Changhai Hospital 96